MENU
+Compare
DNTH
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$20.00
Change
+$0.79 (+4.11%)
Capitalization
591.94M

DNTH Dianthus Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DNTH with price predictions
Jan 08, 2025

DNTH's Stochastic Oscillator is sitting in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DNTH broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on DNTH as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DNTH just turned positive on January 03, 2025. Looking at past instances where DNTH's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

DNTH moved above its 50-day moving average on January 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where DNTH advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.752) is normal, around the industry mean (14.746). P/E Ratio (2.770) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). DNTH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (105.263) is also within normal values, averaging (264.084).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DNTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DNTH is expected to report earnings to fall 19.58% to -303 cents per share on September 18

Dianthus Therapeutics DNTH Stock Earnings Reports
Q2'23
Est.
$-3.04
Q3'23
Missed
by $3.22
Q1'23
Missed
by $0.07
Q4'22
Missed
by $0.02
Q3'22
Beat
by $0.02
The last earnings report on November 09 showed earnings per share of -377 cents, missing the estimate of -56 cents. With 156.25K shares outstanding, the current market capitalization sits at 591.94M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MADSX25.580.36
+1.43%
Morgan Stanley Inst Advantage R6
LBRIX30.040.19
+0.64%
ClearBridge Dividend Strategy FI
RWGIX5.340.03
+0.56%
Wedgewood Institutional
BDOKX10.260.05
+0.49%
iShares MSCI Total Intl Idx K
VTAIX10.60N/A
N/A
Virtus Tactical Allocation I

DNTH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+4.11%
IMNM - DNTH
42%
Loosely correlated
+1.32%
ANNX - DNTH
39%
Loosely correlated
+2.19%
SYRE - DNTH
39%
Loosely correlated
+0.34%
SLDB - DNTH
38%
Loosely correlated
+0.62%
TRDA - DNTH
38%
Loosely correlated
+1.20%
More